Harnessing multi-source data for individualized care in Hodgkin Lymphoma.

ABSTRACT: Hodgkin lymphoma is a rare, but highly curative form of cancer, primarily afflicting adolescents and young adults. Despite multiple seminal trials over the past twenty years, there is no single consensus-based treatment approach beyond use of multi-agency chemotherapy with curative intent. The use of radiation continues to be debated in early-stage disease, as part of combined modality treatment, as well as in salvage, as an important form of consolidation. While short-term disease outcomes have varied little across these different approaches across both early and advanced stage disease, the potential risk of severe, longer-term risk has varied considerably. Over the past decade novel therapeutics have been employed in the retrieval setting in preparation to and as consolidation after auto

SUBMITTER: Parsons SK 

PROVIDER: S-EPMC11382606 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature